Biblio
Export 1210 results:
Author [ Title
Filters: First Letter Of Last Name is R [Clear All Filters]
“Physical Activity and Hippocampal Sub-Region Structure in Older Adults with Memory Complaints.”, J Alzheimers Dis, vol. 61, no. 3, pp. 1089-1096, 2018.
, “Phenotype-Dependent Interactions between N-acetyl-L-Aspartate and Acetyl-CoA in Septal SN56 Cholinergic Cells Exposed to an Excess of Zinc.”, J Alzheimers Dis, vol. 56, no. 3, pp. 1145-1158, 2017.
, “A Phase II Study of Fornix Deep Brain Stimulation in Mild Alzheimer's Disease.”, J Alzheimers Dis, vol. 54, no. 2, pp. 777-87, 2016.
, “A Phase II Randomized Clinical Trial of a Nutritional Formulation for Cognition and Mood in Alzheimer's Disease.”, J Alzheimers Dis, 2015.
, “Phase 3 trials of solanezumab for mild-to-moderate Alzheimer's disease.”, N Engl J Med, vol. 370, no. 4, pp. 311-21, 2014.
, “Pharmacologic and Nutritional Interventions for Early Alzheimer's Disease: A Systematic Review and Network Meta-Analysis of Randomized Controlled Trials.”, J Alzheimers Dis, vol. 99, no. 4, pp. 1173-1186, 2024.
, “PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers.”, J Alzheimers Dis, vol. 60, no. 1, pp. 283-293, 2017.
, “PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers.”, J Alzheimers Dis, vol. 60, no. 1, pp. 283-293, 2017.
, “PET Tau and Amyloid-β Burden in Mild Alzheimer's Disease: Divergent Relationship with Age, Cognition, and Cerebrospinal Fluid Biomarkers.”, J Alzheimers Dis, vol. 60, no. 1, pp. 283-293, 2017.
, “PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI).”, J Alzheimers Dis, vol. 60, no. 2, pp. 439-450, 2017.
, “PET Imaging of Tau Pathology and Relationship to Amyloid, Longitudinal MRI, and Cognitive Change in Down Syndrome: Results from the Down Syndrome Biomarker Initiative (DSBI).”, J Alzheimers Dis, vol. 60, no. 2, pp. 439-450, 2017.
, “Perspectives on Communicating Biomarker-Based Assessments of Alzheimer's Disease to Cognitively Healthy Individuals.”, J Alzheimers Dis, vol. 62, no. 2, pp. 487-498, 2018.
, “Perspectives on Communicating Biomarker-Based Assessments of Alzheimer's Disease to Cognitively Healthy Individuals.”, J Alzheimers Dis, vol. 62, no. 2, pp. 487-498, 2018.
, “Personality Modulates the Efficacy of Art Intervention on Chronic Pain in a Population of Patients with Alzheimer's Disease.”, J Alzheimers Dis, vol. 63, no. 2, pp. 617-624, 2018.
, “Perfusion Neuroimaging Abnormalities Alone Distinguish National Football League Players from a Healthy Population.”, J Alzheimers Dis, vol. 53, no. 1, pp. 237-41, 2016.
, “Perfusion Neuroimaging Abnormalities Alone Distinguish National Football League Players from a Healthy Population.”, J Alzheimers Dis, vol. 53, no. 1, pp. 237-41, 2016.
, “Performance of a smell identification test versus the Mini-Mental Status Exam for the detection of dementia and cognitive impairment among persons with cognitive concerns in primary care.”, J Alzheimers Dis, p. 13872877251345083, 2025.
, “PCSK9 Promotes oxLDL-Induced PC12 Cell Apoptosis Through the Bcl-2/Bax-Caspase 9/3 Signaling Pathway.”, J Alzheimers Dis, vol. 57, no. 3, pp. 723-734, 2017.
, “Patterns of Regional Cerebral Blood Flow as a Function of Age Throughout the Lifespan.”, J Alzheimers Dis, 2018.
, “Patients with Mild Alzheimer's Disease Fail When Using Their Working Memory: Evidence from the Eye Tracking Technique.”, J Alzheimers Dis, vol. 50, no. 3, pp. 827-38, 2016.
, “Patient Engagement: The Fundació ACE Framework for Improving Recruitment and Retention in Alzheimer's Disease Research.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1079-1090, 2018.
, “Patient Engagement: The Fundació ACE Framework for Improving Recruitment and Retention in Alzheimer's Disease Research.”, J Alzheimers Dis, vol. 62, no. 3, pp. 1079-1090, 2018.
, “Pathway-Specific Polygenic Risk Scores as Predictors of Amyloid-β Deposition and Cognitive Function in a Sample at Increased Risk for Alzheimer's Disease.”, J Alzheimers Dis, vol. 55, no. 2, pp. 473-484, 2017.
, “The Pathology of Rapid Cognitive Decline in Clinically Diagnosed Alzheimer's Disease.”, J Alzheimers Dis, vol. 70, no. 4, pp. 983-993, 2019.
, ,